Search

23 Feb 2024: May Yung Tiet is an Honorary Clinical Research Associate studying the role of mitochondrial dysfunction in Ataxia-Telangiectasia. ... She completed her BSc (Hons) Biomedical Science in 2006 and was a Research Associate at the Institute of Cancer Research.

23 Feb 2024: The research being pursued by our three research groups explores the following themes. ... We enable everyone in the UK to participate in the most crucial research.

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Catarina Olimpio. Catarina Olimpio. Catarina Olimpio is a Clinical Genetics specialty registrar at Cambridge University Hospitals currently working with Professor Horvath on a retrospective study of

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Heather Biggs. Heather Biggs. Heather Biggs is the Research Project Manager for the MitoCamb research group. ... in 2019, and is responsible for overseeing the group’s clinical research, from grants,

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Elizabeth Ashby. Elizabeth Ashby. Elizabeth Ashby recently joined the MitoCamb research group as a Clinical Research Coordinator. ... This, combined with her interest in research, led her to pursue

23 Feb 2024: His clinical and research experience have led him to develop a huge interest of the brain mechanisms underlaying the hearing loss rehabilitation, and how these cognitive markers can be used to

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Katherine Schon. Katherine Schon. Katherine Schon is doing a PhD in the clinical and genetic aspects of mitochondrial disorders, supervised by Professor Chinnery and Dr Horvath. ... Katherine’s main

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Remyelination (Theme Lead: Nick Cunniffe). The ARMOUR-One study.

23 Feb 2024: Neurogenetics in 2013 in the Institute of Genetic Medicine as part of the Newcastle Wellcome Trust Centre for Mitochondrial Research. ... In September 2018 Rita took on the post of Director of Research (Clinical) at the Department of Clinical

23 Feb 2024: Recent research suggests that the brain changes the way it responds to sounds when a person has a hearing loss. ... using an action-research protocol.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. ... Wonderful news! Greg Winter today won the Nobel Prize for Chemistry (Shared with George Smith adn Frances Arnold).

23 Feb 2024: themes. This vibrant and multidisciplinary research environment comprises:. the John van Geest Centre for Brain Repair,. ... trials. We are UK pioneers in linking imaging research with electronic healthcare records.

23 Feb 2024: Lopez-Poveda at the University of Salamanca (Spain). The main topic of my research is ‘adaptation to noise’ or ‘temporal effects’, i.e., the better tone detection, amplitude modulation detection, or

23 Feb 2024: Horvath Laboratory. Denisa Hathazi. Denisa Hathazi. PhD. Denisa is a research associate in in the Horvath group since 2019. ... Her current research project studies hereditary mitochondria translational defects affecting muscle and the nervous system.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Our supporters. Institutional Funders. We are very grateful for the financial support, for our research, from these institutions:. ... the family of Catherine Gardiner. the family of Duane Lake. If you

23 Feb 2024: Department of Clinical Neurosciences. Featured news. AI to speed up dementia diagnosis. ... Dr Timothy Rittman is the clinical lead of the QMIN-MC trial, which uses a machine learning algorithm developed by Prof Zoe Kourtzi, research lead at the Alun

23 Feb 2024: Department of Clinical Neurosciences. Stem Cell Neurobiology. Stem Cell Neurobiology includes scientists and clinician scientists whose primary research interest is in the fundamental and translational biology of the stem and progenitor

23 Feb 2024: England Research Consortium.

23 Feb 2024: His research interest includes psychoacoustics, hearing aids prescription formula, cochlear implant coding strategies, clinical assessments and interventions.

23 Feb 2024: STEM-PD uses human embryonic stem cells, a type of cell that can turn into almost any type of […]. Filed Under:12th October 2022. In research published today in Alzheimer’s & ... Filed Under:13th May 2022. The research, from the University of

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Previous staff members. Click photos below to find out more about our previous staff.

23 Feb 2024: Filed Under:10th August 2021. Dr Timothy Rittman is the clinical lead of the QMIN-MC trial, which uses a machine learning algorithm developed by Prof Zoe Kourtzi, research lead at ... The new Fellows have been selected for their exceptional contributions

23 Feb 2024: Jess’ research has led to the launch of a clinical trial, which is testing a new treatment to slow down the […]. Filed Under:5th June 2019. Results indicate that early treatment ... MRC Clinical Director He joins the senior management team and will

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Jelle van den Ameele. Jelle van den Ameele. ... In 2020, Jelle became a Wellcome Clinical Research Career Development Fellow at the Department of Clinical Neurosciences and MRC Mitochondrial Biology Unit

23 Feb 2024: SOUND Laboratory. Marina Salorio-Corbetto. Marina is a Research Associate who has previously worked as a clinical audiologist. ... While at the Auditory Perception Group, Marina started collaborating with Dr Josephine Marriage as a Research Audiologist.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Publications. Six months of bexarotene reduces the VEP latency, implying remyelination (Brown Lancet Neurol 2021). ... PMID: 36116011; PMCID: PMC9539389. Needham EJ, …. Coles AJ, Menon DK; Cambridge

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. CCMR2 Trial Starts. 22nd March 2022. ... purpose of this research is therefore to assess whether metformin and clemastine.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. ... This new research is a major milestone in our plan to stop MS and we’re incredibly excited about the potential it’s shown for future studies.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Psychosis Clinical Trial. SINAPPS-2 trial. SINAPPS2 is a phase II ongoing clinical trial aiming to test the efficacy and safety of immunotherapy (intravenous immunoglobulin combined

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Children with MS. We are exploring changes in myelin and nerve health over time in children with demyelinating diseases, such as multiple sclerosis (MS).

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Anaphylaxis to alemtuzumab. 20th February 2019. ... PubMed PMID: 30715557. Filed Under: News.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Greg Winter Nobel Prize. 3rd October 2018. ... Wonderful news! Greg Winter today won the Nobel Prize for Chemistry (Shared with George Smith adn Frances Arnold).

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Bexarotene trial published! 19th August 2021. ... It is a mixture of good and bad news! Sadly, we concluded that the drug has too many side-effects to take further as a treatment for people with MS.

23 Feb 2024: We enable everyone in the UK to participate in the most crucial research, and we reduce healthcare inequalities. ... To consent to approved research being done at their hospital using their existing information.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Alemtuzumab Trial Results. These are the “headline results” from the three sponsored clinical trial results.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Alemtuzumab (Lemtrada). The history of alemtuzumab use in multiple sclerosis.

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Survey Studies. Please see below for further details on our studies that are designed to assess patient experience.

23 Feb 2024: Our aim is to train excellent neurologists, with subspeciality expertise, and advanced training in research, education or management. ... We aspire to be flexible, responsive and ambitious. For those interested in neuroscience research, all of the

23 Feb 2024: For more details see our website for Clinical MS Research.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Patrick Chinnery appointed as MRC Clinical Director. ... He joins the senior management team and will play a key role in developing, promoting and implementing MRC research programmes, working with

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. NHS England algorithm published. 16th September 2018.

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Treatment Studies. Please see below for further details on our studies that are designed to examine possible treatments.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. Honour awarded to Professor Maria Grazia Spillantini.

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Measuring Studies. Please see below for further details on our studies that aim to measure disease burden.

23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Chloe Seikus. Chloe Seikus. Chloe Seikus joined the Department of Clinical Neurosciences as a research assistant in 2020, where she was responsible for recruiting participants to ... the groups’ research

23 Feb 2024: My research interests have focused on how different brain regions communicate, neural plasticity, neural networks, and how abnormalities in these mechanisms can result in pathology.

23 Feb 2024: Department of Clinical Neurosciences. Featured news. AI could detect dementia years before symptoms appear. ... Filed Under: Featured news.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. EMA lifts restriction on alemtuzumab use.

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. ... Wonderful news! Greg Winter today won the Nobel Prize for Chemistry (Shared with George Smith adn Frances Arnold).

23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Non-disabling relapses count too! 6th March 2023.